Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo-Reference-Cited by-同舟云学术

Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo

Published:2015-03-29 Issue:17 Volume:6 Page:15332-15347
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Sharon Chetna¹,Baranwal Somesh¹,Patel Nirmita J.²,Rodriguez-Agudo Daniel²³,Pandak William M.²³,Majumdar Adhip P. N.⁴,Krystal Geoffrey²⁵¹,Patel Bhaumik B.²⁵¹

Affiliation:

1. Division of Hematology, Oncology and Palliative Care, Virginia Commonwealth University, Richmond, VA, USA

2. Hunter Holmes McGuire VA Medical Center, Richmond, VA, USA

3. Department of Medicine, Division of Gastroenterology, Virginia Commonwealth University, Richmond, VA, USA

4. John D. Dingell VAMC, Detroit, MI, USA

5. Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid metabolism dynamics in cancer stem cells: potential targets for cancers;Frontiers in Pharmacology;2024-06-27

2. Cholesterol in colorectal cancer: an essential but tumorigenic precursor?;Frontiers in Oncology;2023-11-03

3. APCandP53mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer;Gut;2023-08-17

4. Designing Synthetic, Sulfated Glycosaminoglycan Mimetics That Are Orally Bioavailable and Exhibiting In Vivo Anticancer Activity;Journal of Medicinal Chemistry;2023-01-12

5. Metabolism in Cancer Stem Cells: Targets for Clinical Treatment;Cells;2022-11-26